Cargando…

RET mutated C-cells proliferate more rapidly than non-mutated neoplastic cells

A statistically significant higher prevalence of the RET p.Met918Thr somatic mutation, identified by direct sequencing, was previously reported in MTC > 2 cm than in smaller tumors. Aim of this study was to correlate the full RET and RAS mutation profile, identified by a Next Generation Sequencin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Romei, Cristina, Ramone, Teresa, Mulè, Chiara, Prete, Alessandro, Cappagli, Virginia, Lorusso, Loredana, Torregrossa, Liborio, Basolo, Fulvio, Ciampi, Raffaele, Elisei, Rossella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983519/ https://www.ncbi.nlm.nih.gov/pubmed/33475524 http://dx.doi.org/10.1530/EC-20-0589

Ejemplares similares

Higher RET Gene Expression Levels Do Not Represent anAlternative RET Activation Mechanism in Medullary Thyroid Carcinoma
por: Mulè, Chiara, et al.
Publicado: (2021)

RET Copy Number Alteration in Medullary Thyroid Cancer Is a Rare Event Correlated with RET Somatic Mutations and High Allelic Frequency
por: Ramone, Teresa, et al.
Publicado: (2020)

Active Surveillance in RET Gene Carriers Belonging to Families with Multiple Endocrine Neoplasia
por: Prete, Alessandro, et al.
Publicado: (2021)

Genetic Landscape of Somatic Mutations in a Large Cohort of Sporadic Medullary Thyroid Carcinomas Studied by Next-Generation Targeted Sequencing
por: Ciampi, Raffaele, et al.
Publicado: (2019)

RET mutation heterogeneity in primary advanced medullary thyroid cancers and their metastases
por: Romei, Cristina, et al.
Publicado: (2018)

Twenty-Five Years Experience on RET Genetic Screening on Hereditary MTC: An Update on The Prevalence of Germline RET Mutations
por: Elisei, Rossella, et al.
Publicado: (2019)

MON-490 Calcitonin-Based Thyroidectomy Is a Safe Approach in Patients with Germline RET Mutation and Permits to Delay Surgery in Children
por: Prete, Alessandro, et al.
Publicado: (2020)

Impact of Advanced Age on the Clinical Presentation and Outcome of Sporadic Medullary Thyroid Carcinoma
por: Matrone, Antonio, et al.
Publicado: (2020)

BRAF K601E Mutation in Oncocytic Carcinoma of the Thyroid: A Case Report and Literature Review
por: Matrone, Antonio, et al.
Publicado: (2023)

MON-524 Prospective Evaluation of Patients with Encapsulated Classical Variant of Papillary Thyroid Cancer and Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP): Have They A Similar Prognosis?
por: Giani, Carlotta, et al.
Publicado: (2020)

DICER1 somatic mutations strongly impair miRNA processing even in benign thyroid lesions
por: Poma, Anello Marcello, et al.
Publicado: (2019)

A New MEN2 Syndrome with Clinical Features of Both MEN2A and MEN2B Associated with a New RET Germline Deletion
por: Giani, Carlotta, et al.
Publicado: (2020)

Poorly Differentiated and Anaplastic Thyroid Cancer: Insights into Genomics, Microenvironment and New Drugs
por: Prete, Alessandro, et al.
Publicado: (2021)

Clinical, pathological and genetic features of anaplastic and poorly differentiated thyroid cancer: A single institute experience
por: Romei, Cristina, et al.
Publicado: (2018)

Using The Cancer Genome Atlas data to refine the 8th edition of the American Joint Committee on Cancer staging for papillary thyroid carcinoma
por: Poma, Anello Marcello, et al.
Publicado: (2020)

RET/PTC Translocations and Clinico-Pathological Features in Human Papillary Thyroid Carcinoma
por: Romei, Cristina, et al.
Publicado: (2012)

Lung Recurrence of Papillary Thyroid Cancer Diagnosed With Antithyroglobulin Antibodies After 10 Years From Initial Treatment
por: Viola, David, et al.
Publicado: (2018)

The Molecular Signature More Than the Site of Localization Defines the Origin of the Malignancy
por: Matrone, Antonio, et al.
Publicado: (2019)

Predictive Biomarkers in Thyroid Cancer
por: Macerola, Elisabetta, et al.
Publicado: (2022)

Molecular Alterations in Relation to Histopathological Characteristics in a Large Series of Pediatric Papillary Thyroid Carcinoma from a Single Institution
por: Macerola, Elisabetta, et al.
Publicado: (2021)

Outcomes of the Tall-Cell Variant of Papillary Thyroid Carcinoma in Patients with Different Ages: A 17-Year Mono-Institutional Experience
por: Proietti, Agnese, et al.
Publicado: (2023)

Hippo pathway affects survival of cancer patients: extensive analysis of TCGA data and review of literature
por: Poma, Anello Marcello, et al.
Publicado: (2018)

Clinical-Pathological and Molecular Evaluation of 451 NIFTP Patients from a Single Referral Center
por: Vignali, Paola, et al.
Publicado: (2022)

The 5(th) edition of WHO classification of tumors of endocrine organs: changes in the diagnosis of follicular-derived thyroid carcinoma
por: Basolo, Fulvio, et al.
Publicado: (2023)

Down-regulation of miR-7-5p and miR-548ar-5p predicts malignancy in indeterminate thyroid nodules negative for BRAF and RAS mutations
por: Macerola, Elisabetta, et al.
Publicado: (2022)

Response to Letter to the Editor From Green and Gosmanov: “Tall Cell Percentage Alone in PTC Without Aggressive Features Should not Guide Patients’ Clinical Management”
por: Viola, David, et al.
Publicado: (2022)

Core Needle Biopsy Can Early and Precisely Identify Large Thyroid Masses
por: Matrone, Antonio, et al.
Publicado: (2022)

Thyroid cancer and COVID-19: experience at one single thyroid disease referral center
por: Prete, Alessandro, et al.
Publicado: (2021)

Metastasis of renal cell carcinoma to the parathyroid gland 16 years after radical nephrectomy: A case report
por: Torregrossa, Liborio, et al.
Publicado: (2016)

Molecular Genetics of Follicular-Derived Thyroid Cancer
por: Macerola, Elisabetta, et al.
Publicado: (2021)

Active surveillance in differentiated thyroid cancer: a strategy applicable to all treatment categories response
por: Campopiano, Maria Cristina, et al.
Publicado: (2023)

Clinical–Pathological Features and Treatment Outcome of Patients With Hobnail Variant Papillary Thyroid Carcinoma
por: Poma, Anello Marcello, et al.
Publicado: (2022)

Usefulness of second (131)I treatment in biochemical persistent differentiated thyroid cancer patients
por: Gambale, Carla, et al.
Publicado: (2023)

Calcitonin estimation in patients with nodular goiter and its significance for early detection of MTC: european comments to the guidelines of the American Thyroid Association
por: Elisei, Rossella, et al.
Publicado: (2013)

A Narrative Review of Genetic Alterations in Primary Thyroid Epithelial Cancer
por: Romei, Cristina, et al.
Publicado: (2021)

RET Solvent Front Mutations Mediate Acquired Resistance to Selective RET Inhibition in RET-Driven Malignancies
por: Solomon, Benjamin J., et al.
Publicado: (2020)

CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer
por: Cetani, Filomena, et al.
Publicado: (2013)

A nonfunctioning parathyroid carcinoma misdiagnosed as a follicular thyroid nodule
por: Cetani, Filomena, et al.
Publicado: (2015)

Inherited variants in genes somatically mutated in thyroid cancer
por: Campo, Chiara, et al.
Publicado: (2017)

Bilateral testicular metastases of medullary thyroid carcinoma in an adult male with multiple endocrine neoplasia 2A syndrome: case report and review of literature
por: Orsolini, Francesca, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mc44q126imrr9u8omd7k47cnpo